These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
169 related items for PubMed ID: 39377503
1. Histopathological lesions of the gastrointestinal tract associated with the use of polystyrene sulfonate and sevelamer: a meta-analysis. Di Rienzo G, Crafa P, Delsante M, Fiaccadori E, Pedrazzi G, Campanini N, Corradini E. Pathologica; 2024 Aug; 116(4):216-221. PubMed ID: 39377503 [Abstract] [Full Text] [Related]
2. Potassium binders for chronic hyperkalaemia in people with chronic kidney disease. Natale P, Palmer SC, Ruospo M, Saglimbene VM, Strippoli GF. Cochrane Database Syst Rev; 2020 Jun 26; 6(6):CD013165. PubMed ID: 32588430 [Abstract] [Full Text] [Related]
3. Gastrointestinal adverse events with sodium polystyrene sulfonate (Kayexalate) use: a systematic review. Harel Z, Harel S, Shah PS, Wald R, Perl J, Bell CM. Am J Med; 2013 Mar 26; 126(3):264.e9-24. PubMed ID: 23321430 [Abstract] [Full Text] [Related]
4. Exploring co-dispensed drug use in patients on sevelamer or polystyrene sulfonate to identify potential novel binding interactions: a cross sectional in silico study : Potential novel binding interactions with resins. van Berlo-van de Laar IRF, Prins-Can I, Schuiling-Veninga CCM, Taxis K, Jansman FGA. Int J Clin Pharm; 2022 Apr 26; 44(2):389-398. PubMed ID: 34850339 [Abstract] [Full Text] [Related]
5. Risk of Hospitalization for Serious Adverse Gastrointestinal Events Associated With Sodium Polystyrene Sulfonate Use in Patients of Advanced Age. Noel JA, Bota SE, Petrcich W, Garg AX, Carrero JJ, Harel Z, Tangri N, Clark EG, Komenda P, Sood MM. JAMA Intern Med; 2019 Aug 01; 179(8):1025-1033. PubMed ID: 31180477 [Abstract] [Full Text] [Related]
6. Intestinal Necrosis Associated with Orally Administered Calcium Polystyrene Sulfonate Without Sorbitol. Goutorbe P, Montcriol A, Lacroix G, Bordes J, Meaudre E, Souraud JB. Ann Pharmacother; 2011 Feb 01; 45(2):e13. PubMed ID: 21304040 [Abstract] [Full Text] [Related]
7. Sevelamer crystals in the mucosa of the gastrointestinal tract in a teenager with end-stage renal disease. Kim J, Olson K, Butani L. Pediatr Nephrol; 2016 Feb 01; 31(2):339-41. PubMed ID: 26563116 [Abstract] [Full Text] [Related]
11. Meta-analysis of the efficacy and safety of sevelamer as hyperphosphatemia therapy for hemodialysis patients. Zeng Q, Zhong Y, Yu X. Ren Fail; 2023 Dec 01; 45(1):2210230. PubMed ID: 37272189 [Abstract] [Full Text] [Related]
12. Sevelamer Versus Calcium-Based Binders for Treatment of Hyperphosphatemia in CKD: A Meta-Analysis of Randomized Controlled Trials. Patel L, Bernard LM, Elder GJ. Clin J Am Soc Nephrol; 2016 Feb 05; 11(2):232-44. PubMed ID: 26668024 [Abstract] [Full Text] [Related]
14. Sevelamer crystals in the gastrointestinal tract (GIT): a new entity associated with mucosal injury. Swanson BJ, Limketkai BN, Liu TC, Montgomery E, Nazari K, Park JY, Santangelo WC, Torbenson MS, Voltaggio L, Yearsley MM, Arnold CA. Am J Surg Pathol; 2013 Nov 05; 37(11):1686-93. PubMed ID: 24061514 [Abstract] [Full Text] [Related]
15. Patterns of gastrointestinal injury in patients with chronic kidney disease: Comparison of cases with and without sevelamer crystals. Shakeri H, Panarelli NC. Histopathology; 2024 Mar 05; 84(4):624-632. PubMed ID: 38044854 [Abstract] [Full Text] [Related]
16. Hyperkalemia and potential pitfalls of sodium polystyrene sulfonate. Nguyen T, Ondrik D, Zhufyak O, To W, He S. JAAPA; 2015 Mar 05; 28(3):41-5. PubMed ID: 25710403 [Abstract] [Full Text] [Related]
17. The Successful Treatment of Sodium Polystyrene Sulfonate-induced Enteritis Diagnosed by Small Bowel Endoscopy. Okayama K, Hirata Y, Kumai D, Yamamoto Y, Kojima Y, Kanno T, Ikeuchi H, Mochizuki H, Takada H, Sobue S. Intern Med; 2018 Jun 01; 57(11):1577-1581. PubMed ID: 29321412 [Abstract] [Full Text] [Related]